Integrichain Blog

Blog

Three Pharma regulatory consultants working at a table and planning their pharma gross-to-net strategy

Contracts & Pricing Brian Bumpus Sarah Vo Carter Hall
September 27, 2022

FSS Public Law, US Territory Inclusion, and Branded Prescription Fee Invoice

4 Minute Read

Regulatory and legal updates on four significant regulatory topics, including the Inflation Reduction Act and FSS Public Law updates.

pharmaceutical pricing strategy reporting

Contracts & Pricing Jeff Baab
August 29, 2022

The Impact of the Inflation Reduction Act on the Pharmaceutical Industry

4 Minute Read

Explore some of the key provisions and timelines of the Inflation Reduction Act for their impact on pharmaceutical manufacturers government pricing and GTN strategies.

Pharmaceutical distribution channel analytics

Contracts & Pricing Olivia Nweze Darren Schneider Michael Gorokhovsky
August 19, 2022

NDC Format Proposal, Focus on PBMs, False Claims Act

4 Minute Read

August's market update is a legislative review of the NDC formal proposal, FTC investigation of PBMs, and the False Claims Act.

Contract Banner

Contracts & Pricing Brian Bumpus Suzaun Shahamat
July 19, 2022

Legal Review: Medicare Program, 340B, and State Price Updates

6 Minute Read

July's market update is a legislative review of 340B contract pharmacy restrictions, new Medicare bills, and SPTR updates.

Channel Samer Allabadi
July 13, 2022

Top Trends in Specialty Network and Service Design

5 Minute Read

Benchmarks on specialty networks using our exclusive ICyte channel and patient access data: what specialty networks look like, who's included, and how network sizes vary by therapeutic category.

Contracts & Pricing Marta Rutherford Michael Gorokhovsky
June 27, 2022

Pharma vs. 340B

4 Minute Read

This month’s market update features the latest news detailing the tumultuous relationship between pharma and 340B, including The Supreme Court, HRSA, and insight on how inflation escalates everything.

pharmaceutical pricing strategy reporting

Contracts & Pricing Jeff Baab
June 14, 2022

Top Trends in Contracting

6 Minute Read

Using exclusive ICyte Benchmarks from over 230 brands across more than 50 manufacturers, we examine the top trends in specialty pharmacy contracting.

orphan drug

Launch Readiness Dave Weiss
June 7, 2022

Best Practices: Identifying and Avoiding Patient Access Barriers

4 Minute Read

Market access leaders from DBV Technologies, Sesen Bio, and Karyopharm Therapeutics discuss strategies to overcome obstacles to patient initiation and adherence.

Capitol Building, where state price transparency laws are enacted

Government Pricing Stephanie Trunk John Whitridge
May 26, 2022

The Nuance and Necessity of Timely State Price Transparency Reporting

4 Minute Read

Expert opinions from a recent price transparency congress on reporting, remediation, and ways to manage state price transparency now and in the future.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article